4Maleney DG, Liles TM, Czerwinski DK, et al. Phase I clinical trial using escalating sing-dose infusion of chimeric anti-CD20 monoclonal antibody(IDED-C2B8) in patients with recurrent B-cell lymphoma[J].Blood, 1994, 84(8): 2457-2466. 被引量：1
5Shan D, ledbetter JA, Press OW. Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies[J].Blood, 1998, 91 (5): 1644-1652. 被引量：1
6Golay J, Zaffaroni L, Vaccari T, et al. Biologic response of B-lymphoma ceils to anti-CD20 monoclonal antibody rituximab in vitro:CD55 and CD59 regulate complement-mediated ceil lysis[J].Blood, 2000, 95(12): 3900-3908. 被引量：1
7Ghetie MA, Bright H, Vitetta ES. Homodimers but notmonomers of Rimxan(chimeric anti-CD20) induce apoptosis in human B-lymphoma cells and synergize with a chemothera-peutic agent and an immunotoxin[J]. Blood, 2001, 97(5): 1392-1398. 被引量：1
8Vose JM, Link B K, GrossbardM L, et al. Phase Ⅱ study of Rit-uximab in combination with CHOP chemotherapy in patients with previously untreated, aggessive non-Hodgkin' s lymphoma [J]. J Clin Oncol, 2001, 19(2): 389-397. 被引量：1
1Rubenstein J,Ferreri M,Pittaluga S. Primary lymphoma of the central nervous system:epidemiology,pathology and current approaches to diagnosis,prognosis and treatment[J].Leukemia and Lymphoma,2008,(S 1):43-51. 被引量：1
2O' Neill B,Janney C,Olson J. The continuing increase in primary central nervous system non-Hodgkin' s lymphoma (PCNSL):a surveillance, epidemiologyand end results (SEER) analysis[J].Proceedings of the American Society of Clinical Oncology,2001.53. 被引量：1
3Ferreri AJ,Abrey LE,Blay JY. Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma,Lugano,Switzerland,June 12 to 15,2002[J].Journal of Clinical Oncology,2003.2407-2414. 被引量：1
4Shah GD,Yahalom J,Correa DD. Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma[J].Journal of Clinical Oncology,2007.4730-4735. 被引量：1
5DeAngelis LM. Primary CNS lymphoma:Treatment with combined chemotherapy and radiotherapy[J].Journal of Neuro-Oncology,1999.249-257. 被引量：1
6Rubenstein JL,Combs J,Rosenberg LA. Rituximab in CNS lymphoma:targeting the leptomeningeal compartment[J].Blood,2003.466-468. 被引量：1
